Insider Selling: Docusign (NASDAQ:DOCU) Director Sells 3,000 Shares of Stock

Key Points

  • Director sale: Non‑executive director Mary Agnes Wilderotter sold 3,000 shares on April 1 at an average $48.15, cutting her stake by about 4.78% to 59,803 shares.
  • Broader insider selling: The director's sale adds to a wave of insider selling this week — CEO Allan Thygesen (26,250 shares) and other senior executives also sold significant holdings (many via Rule 10b5‑1 plans), which may weigh on sentiment.
  • Company fundamentals and buyback: DocuSign beat Q3 estimates (EPS $1.01 vs $0.95; revenue $836.9M, +7.8% YoY) and the board authorized a $2.0 billion repurchase (~21% of shares), but analysts have trimmed targets and the consensus rating remains a "Hold" (average target $64.67).

Docusign Inc. (NASDAQ:DOCU - Get Free Report) Director Mary Agnes Wilderotter sold 3,000 shares of the stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $48.15, for a total value of $144,450.00. Following the completion of the transaction, the director owned 59,803 shares in the company, valued at $2,879,514.45. This represents a 4.78% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Docusign Stock Performance

Shares of DOCU opened at $48.37 on Friday. The firm has a market cap of $9.40 billion, a PE ratio of 32.68, a PEG ratio of 1.88 and a beta of 0.99. The firm's 50 day moving average price is $47.40 and its 200 day moving average price is $61.85. Docusign Inc. has a twelve month low of $40.16 and a twelve month high of $94.67.

Docusign (NASDAQ:DOCU - Get Free Report) last posted its earnings results on Tuesday, March 17th. The company reported $1.01 EPS for the quarter, topping the consensus estimate of $0.95 by $0.06. Docusign had a net margin of 9.60% and a return on equity of 16.86%. The company had revenue of $836.86 million during the quarter, compared to the consensus estimate of $828.23 million. During the same period in the previous year, the firm posted $0.86 earnings per share. The company's revenue for the quarter was up 7.8% compared to the same quarter last year. On average, sell-side analysts anticipate that Docusign Inc. will post 1.17 earnings per share for the current fiscal year.




Docusign announced that its board has initiated a stock repurchase plan on Tuesday, March 17th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the company to reacquire up to 21% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company's management believes its shares are undervalued.

Institutional Trading of Docusign

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Central Pacific Bank Trust Division bought a new position in Docusign in the 4th quarter worth approximately $25,000. Modus Advisors LLC bought a new stake in shares of Docusign in the fourth quarter valued at approximately $27,000. Torren Management LLC bought a new stake in shares of Docusign in the fourth quarter valued at approximately $28,000. Aventura Private Wealth LLC acquired a new stake in shares of Docusign in the fourth quarter worth $30,000. Finally, True Wealth Design LLC grew its stake in shares of Docusign by 105.2% in the fourth quarter. True Wealth Design LLC now owns 433 shares of the company's stock worth $30,000 after acquiring an additional 222 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company's stock.

Analyst Upgrades and Downgrades

DOCU has been the topic of several recent research reports. JPMorgan Chase & Co. cut their target price on Docusign from $78.00 to $65.00 and set a "neutral" rating on the stock in a report on Wednesday, March 18th. Wells Fargo & Company decreased their price target on Docusign from $75.00 to $60.00 and set an "equal weight" rating for the company in a research note on Wednesday, March 18th. Citizens Jmp lowered their price objective on Docusign from $124.00 to $86.00 and set a "market outperform" rating on the stock in a report on Wednesday, March 18th. Needham & Company LLC reissued a "hold" rating on shares of Docusign in a research note on Tuesday, March 10th. Finally, Citigroup reduced their target price on Docusign from $120.00 to $99.00 and set a "buy" rating for the company in a report on Wednesday, March 18th. Five equities research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $64.67.

Read Our Latest Stock Analysis on Docusign

Docusign News Summary

Here are the key news stories impacting Docusign this week:

  • Positive Sentiment: Q3 results topped expectations — DOCU reported $1.01 EPS vs. $0.95 consensus and revenue of $836.9M, with revenue up ~7.8% YoY, signaling continued growth and margin improvement. MarketBeat DOCU summary
  • Positive Sentiment: Board authorized a $2.0 billion buyback (up to ~21% of shares) — a large repurchase program that management says indicates shares are undervalued and can support the share price over time. MarketBeat DOCU summary
  • Positive Sentiment: Institutional accumulation — several large funds (Norges Bank, Capital World, Arrowstreet, Marshall Wace, Woodline) materially increased positions in recent quarters, which can provide steadier demand for the shares. MarketBeat DOCU institutional holdings
  • Neutral Sentiment: Analyst mix remains split — consensus is a “Hold” with a $64.67 average target; broker price targets and ratings vary widely (from Underperform to Buy), leaving near‑term analyst-driven directional risk moderate. MarketBeat analyst coverage
  • Negative Sentiment: Significant insider selling this week — CEO Allan Thygesen sold 26,250 shares (avg ~$47.78) under a Rule 10b5‑1 plan. This is a sizable reduction in his stake and has likely weighed on sentiment. CEO Form 4
  • Negative Sentiment: CRO Paula Hansen and insider James P. Shaughnessy sold 6,000 and 12,000 shares respectively (each at ~\$46.8), both reported as executed under pre-arranged 10b5‑1 plans — multiple senior exits in one day can pressure sentiment despite plan disclosures. CRO Form 4
  • Negative Sentiment: Non‑executive director Mary Agnes Wilderotter sold 3,000 shares (~\$48.15), further adding to the week’s insider selling flow. Director Form 4

About Docusign

(Get Free Report)

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company's flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign's Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign's platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

See Also

Insider Buying and Selling by Quarter for Docusign (NASDAQ:DOCU)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Docusign?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Docusign and related companies.
From Our Partners
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles